Related Experiment Video
Updated: Dec 24, 2025

Visualizing Lung Cellular Adaptations during Combined Ozone and LPS Induced Murine Acute Lung Injury
Published on: March 21, 2021
COVID-19 in the heart and the lungs: could we "Notch" the inflammatory storm?
Paola Rizzo1,2, Francesco Vieceli Dalla Sega3, Francesca Fortini3
1Department of Morphology, Surgery and Experimental Medicine and Laboratory for Technologies of Advanced Therapies (LTTA), University of Ferrara, Ferrara, Italy. rzzpla@unife.it.
Insights
This study explores targeting Notch signaling to combat severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and mitigate COVID-19-related heart and lung complications. Modulating this pathway may offer a novel therapeutic strategy for viral infections and associated cardiovascular disease.
Area of Science:
- Cardiovascular Biology
- Virology
- Molecular Signaling
Background:
- Coronavirus disease (COVID-19), caused by SARS-CoV-2, has led to a global health crisis.
- Cardiac complications like myocarditis and heart failure are observed in COVID-19 patients, indicating a link between SARS-CoV-2 infection and cardiovascular disease.
- Notch signaling is crucial for cardiovascular function and plays a role in viral infection pathways.
Discussion:
- This report investigates the potential of targeting Notch signaling as a therapeutic strategy against SARS-CoV-2.
- Interfering with Notch signaling could prevent viral entry or replication.
- Modulating Notch signaling may also address COVID-19-associated cardiac and pulmonary pathologies.
Key Insights:
- A potential therapeutic target for COVID-19 and its cardiac sequelae is identified.
- The role of Notch signaling in both cardiovascular health and viral pathogenesis is highlighted.
- This research opens avenues for novel treatment strategies.
Outlook:
- Further research is needed to validate Notch signaling as a therapeutic target for COVID-19.
- Preclinical and clinical studies are required to assess the safety and efficacy of Notch pathway modulators.
- This approach could lead to new treatments for viral myocarditis and other cardiovascular complications.
Abstract:
From January 2020, coronavirus disease (COVID-19) originated in China has spread around the world. The disease is caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The presence of myocarditis, cardiac arrest, and acute heart failure in COVID-19 patients suggests the existence of a relationship between SARS-CoV-2 infection and cardiac disease. The Notch signalling is a major regulator of cardiovascular function and it is also implicated in several biological processes mediating viral infections. In this report we discuss the possibility to target Notch signalling to prevent SARS-CoV-2 infection and interfere with the progression of COVID-19- associated heart and lungs disease.
Related Concept Videos
Myocarditis I: Introduction
Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
COPD: Pathogenesis and Clinical Features
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
Chronic Inflammation
Rheumatic Heart Disease I: Introduction
Psychoneuroimmunology: Cardiovascular Disease
A key area of focus in PNI is the relationship between stress and coronary...

